Changes in Hypertension Prevalence, Awareness, Treatment, and Control in High-, Middle-, and Low-Income Countries: An Update

被引：0
作者：
Renata Cifkova
George Fodor
Peter Wohlfahrt
机构：
[1] Charles University in Prague,Center for Cardiovascular Prevention, First Faculty of Medicine and Thomayer Hospital
[2] Charles University Medical School I,Department of Medicine II
[3] St. Anne᾿s University Hospital,International Clinical Research Center – Department of Cardiovascular Diseases
[4] University of Ottawa,Ottawa Heart Institute
来源：
Current Hypertension Reports | 2016年 / 18卷
关键词：
Hypertension; Epidemiology; Pharmacotherapy; Lifestyle changes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The aim of this paper was to critically evaluate recent publications on hypertension treatment and control in regions by income. Prevalence of hypertension is increasing worldwide, most prominently in low-income countries. Awareness, treatment, and control are most successful in North America while remaining a challenge in middle- and low-income countries. Easy access to medical care and aggressive use of pharmacotherapy are the key strategies which have proved to be successful in reducing the burden of hypertension on the population level.
引用
收藏
相关论文
共 125 条
[21]  
Gee M(2014)Prevalence of hypertension in member countries of South Asian Association for Regional Cooperation (SAARC): systematic review and meta-analysis Medicine (Baltimore) 93 e74-110
[22]  
Myers MG(2007)González-Esteban J; on behalf of the investigators of the PREV-ICTUS Study. Differences in blood pressure control and stroke mortality across Spain. The Prevención de Riesgo de Ictus (PREV-ICTUS) Study Hypertension 49 799-95
[23]  
McInnis NH(2011)Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure Eur Heart J 32 1424-undefined
[24]  
Fodor GJ(2008)Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004 Hypertension 52 818-undefined
[25]  
Leenen FH(2016)Commentary: accepting what we don't know will lead to progress Int J Epidemiol 45 260-undefined
[26]  
Törmä E(2011)Salt reduction initiatives around the world J Hypertens 29 1043-undefined
[27]  
Carlberg B(2007)The value of antihypertensive drugs: a perspective on medical innovation Health Aff (Millwood) 26 97-undefined
[28]  
Eriksson M(2015)New approaches in the treatment of hypertension Circ Res 116 1074-undefined
[29]  
Jansson JH(undefined)undefined undefined undefined undefined-undefined
[30]  
Eliasson M(undefined)undefined undefined undefined undefined-undefined
12345678910